10 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 10 of 10 clinical reviews.
A guide covering how dutasteride affects concentration, fatigue, sports eligibility, and academic performance in adolescents ages 12 to 17 prescribed Avodart for androgenetic alopecia or other off-label indications.
Complete caregiver guidance for administering dutasteride (Avodart) to patients aged 65 and older: dosing, safety precautions, handling rules, monitoring schedules, and when to call the prescriber.
A clinical review of how dutasteride (Avodart) affects men aged 65 and older, covering pharmacokinetics, BPH outcomes, prostate cancer risk, sexual side effects, cognitive concerns, and dosing guidance for geriatric patients.
A guide to how dutasteride (Avodart) affects cognitive function, driving, physical activity, and daily scheduling in adults aged 65 and older, with primary-source citations throughout.
A clinical review of dutasteride (Avodart) use in pediatric patients under age 12, covering hormonal developmental risks, FDA contraindications, 5-alpha reductase physiology in childhood, and what the evidence actually shows.
A clinical guide to dutasteride use in pediatric patients under age 12 and what the transition to adult endocrinology or urology care looks like, including FDA status, trial evidence, dosing considerations, and monitoring protocols.
A guide to dutasteride use in men 65 and older, covering pharmacokinetics, BPH and prostate cancer risk reduction, safety monitoring, and how care transitions affect dosing and follow-up.
A clinical guide for caregivers administering dutasteride (Avodart) to adolescents aged 12 to 17, covering dosing, handling precautions, missed doses, storage, and when to call the prescriber.
A clinical deep-dive into dutasteride (Avodart) use in adolescents aged 12-17, covering hormonal development, DHT suppression risks, sexual maturation, bone health, fertility, and FDA prescribing guidance.
Complete caregiver guidance on dutasteride (Avodart) in children under 12: why it is contraindicated, teratogenic risks, accidental exposure protocols, and what FDA labeling actually says.